15 Apr “Biotest at the forefront of combating Covid-19” Posted at 10:16h in Sem categoria by Rita Cardoso Biotest participates in the intersectoral initiative of the pharmaceutical industry with the aim of producing life-saving drugs derived from the plasma of cured COVID-19 patients. COVID-19 is also developing a therapy for patients with severe disease with Trimodulin. Print page
